within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J05A_DirectActingAntivirals.J05AR19_EmtricitabineTenofovirAl;

model EmtricitabineTenofovirAl
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.8,
    Cl = 6.944444444444445e-06,
    adminDuration = 600,
    adminMass = 200 / 1000000,
    adminCount = 1,
    Vd = 0.0014,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.018333333333333333,
    Tlag = 96.0);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>EmtricitabineTenofovirAlafenamideAndRilpivirine</td></tr><tr><td>ATC code:</td><td>J05AR19</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>200</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>1.4</td><td>L</td></tr>
    <tr><td>clearance:</td><td>25</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Fixed-dose combination tablet containing emtricitabine (NRTI), tenofovir alafenamide (NRTI prodrug), and rilpivirine (NNRTI); used as a complete regimen for the treatment of HIV-1 infection in adults and adolescents. The drug is currently approved for clinical use for HIV-1 management.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult HIV-negative volunteers after single-dose oral administration. Parameter values are approximated based on separate published PK profiles for each component, as no population PK publication exists for the fixed combination product.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.J.J05AR19 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end EmtricitabineTenofovirAl;
